Efficacy of COVID convalescent plasma therapy in hospitalized moderate coronavirus disease 2019 patients.

Cosphiadi Irawan,Cleopas Martin Rumende,Lugyanti Sukrisman,Ceva Wicaksono Pitoyo,Suhendro Suwarto,Adityo Susilo,Nadia Ayu Mulansari, Alvin Tagor Harahap,Dimas Priantono, Ria Syafitri, Saptuti Chunaeni,Ni Ken Ritchie

Journal of infection in developing countries（2023）

引用 1|浏览1

暂无评分

摘要

This study concluded that in hospitalized moderate COVID-19 patients, CCP did not reduce 14-day mortality compared to the control. Mortality during 28 days and total length of stay (41 days) were lower in the CCP group compared to the control, although they did not reach statistical significance.

查看译文

关键词

COVID Convalescent plasma,COVID-19,mortality

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要